Table 1 Clinical characteristics of healthy control and T2DM patients
|  | Healthy control N = 76 | T2DM N = 259 | P-value |
|---|---|---|---|
N (male/femal) | 40/36 | 149/110 | 0.450 |
AGE (yrs) | 56.24 ± 8.59 | 56.33 ± 11.49 | 0.940 |
SBP (mmHg) | 117.36 ± 12.79 | 137.71 ± 20.89 | 0.000 |
DBP (mmHg) | 76.00 ± 7.79 | 83.44 ± 11.40 | 0.000 |
Cr (umol/L) | 64.80 ± 14.61 | 75.03 ± 31.73 | 0.000 |
CYS-C (mg/L) | 0.97 ± 0.21 | 1.17 ± 0.50 | 0.000 |
SOD (U/mL) | 106.70 ± 10.69 | 82.01 ± 25.78 | 0.000 |
FPG (mmol/L) | 5.36 ± 0.36 | 9.45 ± 3.33 | 0.000 |
TC (mmol/L) | 4.26 ± 0.52 | 4.46 ± 1.22 | 0.038 |
TG (mmol/L) | 1.18 ± 0.42 | 2.19 ± 1.89 | 0.000 |
HDL-C (mmol/L) | 1.41 ± 0.20 | 1.21 ± 0.32 | 0.000 |
LDL-C (mmol/L) | 2.31 ± 0.41 | 2.53 ± 0.80 | 0.002 |
apoA-I (g/L) | 1.66 ± 0.26 | 1.29 ± 0.34 | 0.000 |
apoB (g/L) | 0.75 ± 0.18 | 0.90 ± 0.33 | 0.000 |
LP (a) (mg/L) | 131.51 ± 113.31 | 157.07 ± 191.36 | 0.269 |
apoM (ng/uL) | 24.48 ± 11.45 | 20.17 ± 10.03 | 0.004 |